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Hypereosinophilia with Multiple
Thromboembolic Cerebral Infarcts and
Focal Intracerebral Hemorrhage
We report a case of hypereosinophilia causing multiple areas of cerebral
infarcts. A 52-year-old Korean man presented with dysarthria and weakness in
both arms. A brain MRI revealed multiple acute infarcts in the distal border zone
with focal intracerebral hemorrhage, whereas a cerebral angiogram was not
remarkable. The eosinophil count was 5,500/μ L and was accompanied by elevat-
ed cardiac enzyme levels. The pattern of cerebral infarcts and laboratory results
suggest a thromboembolic infarction associated with hypereosinophilia.
ypereosinophilia is characterized by an elevated eosinophil count (greater
than 1,500/μ L), and can present with neurological manifestations, includ-
ing encephalopathy, sensory polyneuropathy and cerebral infarction (1).
The cause of cerebral infarction is thought to be a thromboembolism or the
cerebrovascular endothelial toxicity of eosinophils (2). A thromboembolism may affect
the vascular border zone, which is usually related to infarction from prolonged
systemic hypotension or proximal carotid arterial obstruction (3). 
We report a patient with hypereosinophilia, extensive cerebral infarction which was
primarily affecting the border zone, focal intracerebral hemorrhaging and a negative
cerebral angiographic result. The distinguishing feature of our case was the occurrence
of focal intracerebral hemorrhaging, but a negative cerebral angiographic result, which
has not previously been reported. The occurrence of focal intracerebral hemorrhaging
may suggest direct endothelial injury or vasculitis by eosinophilic infiltration as well as
a distant thromboembolism.
CASE REPORT
A 52-year-old man was admitted after a 1-month history of general weakness which
was aggravated three days before an emergency room visit. An initial neurologic
examination revealed disorientation of time, place, person, attention deficit, immedi-
ate memory disturbance, dysarthria, weakness of bilateral upper extremities with
increased deep tendon reflex and right hemiparetic gate. The blood work noted an
elevated eosinophil count (5,500/μ L, 41% of whole white blood cells). The patient’s
clinical history and basic examinations did not lend a clue to any identifiable cause of
hypereosinophilia, which includes parasitic infection, neoplasm, vasculitis or allergy.
Additionally, the patient had no prior clinical symptoms or signs suggesting the
occurrence of Churg-Strauss syndrome, which includes sinusitis or asthma. The cardiac
enzymes were increased by 7.3 ng/ml of creatine kinase-MB and 4.78 ng/ml of
troponin-I. An echocardiogram revealed mild left ventricular inferior wall hypokine-
sia. A diffusion-weighted brain MRI revealed multiple acute infarcts in bilateral border
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Hzones, as well as randomly distributed cortices (Fig. 1A).
Focal intracerebral hemorrhaging was noted on the left
frontal white matter on T2-weighted and gradient echo
images (Fig. 1B, C). A chest CT revealed multiple nodules
in both lungs (Fig. 1D). An MR angiography and conven-
tional cerebral digital subtraction angiography did not
show any evidence of arterial or venous sinus abnormali-
ties (Fig. 1E-H). 
Under the diagnosis of acute hypereosinophilic
syndrome, treatment consisted of 60 mg/day of
prednisolon and 100 mg/day of aspirin. Clinical improve-
ment was noted on the third day of treatment and the
patient was discharged after two weeks with a full
recovery of his general condition and no neurologic deficit.
DISCUSSION
Idiopathic hypereosinophilic syndrome is defined by 1)
persistent eosinophilia of 1,500/μ L or greater for at least
six months or death before six months with signs and
symptoms of hypereosinophilic syndrome disease, 2) lack
of evidence of parasitic, allergic, or other recognized
causes of eosinophilia despite careful examination, and 3)
signs and symptoms of organ system involvement (4). Our
patient did not fulfill one of these criteria due to an acutely
manifested symptom. Though there was no recognized
cause of eosinophilia, the diagnosis of our case would be
acute hypereosinophilia rather than idiopathic eosinophilic
syndrome.
In our patient, the organ involvement of eosinophils
resulted in cerebral infarcts, increased cardiac enzymes and
multiple lung nodules. The cerebral infarcts were noted at
Lee et al.
512 Korean J Radiol 10(5), Sep/Oct 2009
Fig. 1. Hypereosinophilia with multiple thromboembolic cerebral
infarcts and focal intracerebral hemorrhaging in 52-year-old man.
A-C. Diffusion-weighted image (A) reveals multiple acute infarcts in
bilateral border zones. T2-weighted image (B) and gradient echo
image (C) reveal focal intracerebral hemorrhaging (arrows) at left
frontal white matter.
D. Axial high resolution CT scan of lung reveals multiple nodules
(arrows).
ABC
Dthe vascular border zone as well as randomly distributed
cortices. The absence of prolonged systemic hypotension
episodes and negative cerebral angiographic results may
suggest distal arteriolar occlusion related to local thrombi
or distant microemboli and spontaneous resolution. In a
patient with hypereosinophilia, the source of thromboem-
bolism is known to be the eosinophilic involvement of
cardiac endocardium and cerebral arteriolar endothelium,
because activated eosinophils injure human endothelial
cells by releasing a number of cytopathic substances such
as major basic protein (2). Major basic protein is a potent
stimulator of platelet activation and aggregation which
binds to thrombomodulin and reduces its ability to inhibit
the clotting cascade (5). Cardiac endothelial injury is often
extensive and results in fibrosis and thrombosis of endocar-
dial surfaces, though it may be clinically silent at the early
stages of disease (6). The thrombi made in the heart can
induce cerebral infarcts or a pulmonary embolism.
Hypereosinophilia with Multiple Thromboembolic Cerebral Infarcts and Focal Intracerebral Hemorrhaging
Korean J Radiol 10(5), Sep/Oct 2009 513
EF
Fig. 1. Hypereosinophilia with multiple thromboembolic cerebral infarcts and focal intracerebral hemorrhaging in 52-year-old man.
E-H. Cerebral MR angiography (E) and digital subtraction angiography (F-H) shows no evidence of arterial or venous sinus abnormali-
ties.
GHElevated cardiac enzymes and mild left ventricular hypoki-
nesia on the echocardiogram in our patient might be
related to cardiac involvement of hypereosinophilia or co-
existing ischemic heart disease. However, a specific
diagnosis could not be made because further extensive
cardiac examination was not available.  
In cerebral arteries, both thromboembolic infarction and
direct eosinophilic toxicity may be caused by hypere-
osinophilia. Microthromboemboli preferentially embolize
along vessels to the border zones. This was proved by a
prior experimental report and was related to the size of the
embolic particles (7). Thus, as shown in our case, the
cerebral infarctions are produced at the vascular border
zone as well as randomly distributed cortices. The main
mechanism of eosinophilic toxicity to cerebral arteriolar
endothelial cells was thought to be through the production
of the tumor necrosis factor (TNF)-α mediated by an
eosinophil cationic granular protein and resultant multiple
arteriolar fibrinocruoric thrombi (8). 
Hypereosinophilia and its neurologic manifestations have
been discussed in many previous reports. However, no
report of a case with focal intracerebral hemorrhaging and
angiographic demonstration of an intact cerebral vascula-
ture has been reported. The focal intracerebral hemorrhag-
ing in our patient was thought to be unusual because the
individual infarct size was not large and no bleeding
diathesis was observed. This may suggest that there could
be direct endothelial injury or vasculitis caused by
eosinophilic infiltration as well as distant thromboem-
bolism. 
Another possible mechanism of the border zone infarct is
blood hyperviscosity with local thrombus formation. Both
border zone infarcts in extreme hypereosinophilia, as well
as hyperviscosity states from polycythemia vera have been
reported (9, 10). However, even in those cases, the cause
of cerebral infarcts is more likely a microthromboembolism
related to a prothrombotic state rather than local arterial
thrombosis, unless the gross arterial or venous obstructions
were demonstrated on angiograms (10). Therefore, the
latter scenario was not applicable to our patient.
This case suggests that multiple cerebral infarcts in the
vascular border zone without a specific recognizable cause,
as well as cerebral angiographic abnormalities, can be a
cause of neurologic manifestation associated with hypere-
osinophilia. Though the infarct sizes are not extensive,
intracerebral hemorrhaging may be accompanied with
infarcts related to hypereosinophilia. Hence, in such cases,
the administration of antithrombotic drugs is very
important.
References
1. Prick JJ, Gabree ¨ls-Festen AA, Korten JJ, van der Wiel TW.
Neurological manifestations of the hypereosinophilic syndrome
(HES). Clin Neurol Neurosurg 1988;90:269-273
2. Moore PM, Harley JB, Fauci AS. Neurologic dysfunction in the
idiopathic hypereosinophilic syndrome. Ann Intern Med
1985;102:109-114
3. Torvik A. The pathogenesis of watershed infarcts in the brain.
Stroke 1984;15:221-223
4. Chusid MJ, Dale DC, West BC, Wolff SM. The hypere-
osinophilic syndrome: analysis of fourteen cases with review of
the literature. Medicine (Baltimore) 1975;54:1-27
5. Slungaard A, Vercellotti GM, Tran T, Gleich GJ, Key NS.
Eosinophil cationic granule proteins impair thrombomodulin
function. A potential mechanism for thromboembolism in
hypereosinophilic heart disease. J Clin Invest 1993;91:1721-
1730
6. Sarazin M, Caumes E, Cohen A, Amarenco P. Multiple
microembolic borderzone brain infarctions and endomyocardial
fibrosis in idiopathic hypereosinophilic syndrome and in
Schistosoma mansoni infestation. J Neurol Neurosurg
Psychiatry 2004;75:305-307
7. Pollanen MS, Deck JH. The mechanism of embolic watershed
infarction: experimental studies. Can J Neurol Sci 1990;17:395-
398
8. Slungaard A, Vercellotti GM, Walker G, Nelson RD, Jacob HS.
Tumor necrosis factor alpha/cachectin stimulates eosinophil
oxidant production and toxicity towards human endothelium. J
Exp Med 1990;171:2025-2041
9. McMillan HJ, Johnston DL, Doja A. Watershed infarction due
to acute hypereosinophilia. Neurology 2008;70:80-82
10. Koennecke HC, Bernarding J. Diffusion-weighted magnetic
resonance imaging in two patients with polycythemia rubra vera
and early ischemic stroke. Eur J Neurol 2001;8:273-277
Lee et al.
514 Korean J Radiol 10(5), Sep/Oct 2009